MedTrace Logo

Clinical and Biological Efficacy of Hazelnut Oral Immunotherapy

NCT03048149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-01-25

No results posted yet for this study

Summary

This study is retrospective. It focuses on hazelnut allergic patients with a clinical history and a positive specific immunoglobulin E (sIgE) against hazelnut and its recombinants that have followed a hazelnut oral tolerance induction at the allergy Unit of Saint Vincent Hospital of Lille (France) since 2011.

Conditions

  • Allergy

Sponsors & Collaborators

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Tomas Moraly · GHICL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-03-08
Completion
2017-03-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03048149 on ClinicalTrials.gov